Bionano Genomics, Inc. Revenue
Bionano Genomics, Inc. (BNGO) reported Revenue of $8.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-10
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $8.17M, a 21.36% increase year-over-year.
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $6.69M, a 3.56% increase year-over-year.
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $7.95M, a 2.60% decline year-over-year.
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $7.37M, a 21.31% increase year-over-year.
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $28.51M, a 7.37% decline from fiscal 2024.
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $30.78M, a 14.79% decline from fiscal 2023.
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $36.12M, a 29.90% increase from fiscal 2022.
- Bionano Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $27.80M, a 54.62% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.17M 10-Q · filed 2026-08-10 | $14.86M 10-Q · filed 2026-08-10 | $22.81M derived: sum of 3 quarters · filed 2026-08-10 | $30.18M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $6.69M 10-Q · filed 2026-05-13 | $14.64M derived: sum of 2 quarters · filed 2026-05-13 | $22.00M derived: sum of 3 quarters · filed 2026-05-13 | $28.74M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $7.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $15.32M derived: sum of 2 quarters · filed 2026-03-23 | $22.05M derived: sum of 3 quarters · filed 2026-08-10 | $28.51M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $7.37M 10-Q · filed 2025-11-13 | $14.10M derived: sum of 2 quarters · filed 2026-08-10 | $20.56M 10-Q · filed 2025-11-13 | $28.72M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $6.73M 10-Q · filed 2026-08-10 | $13.19M 10-Q · filed 2026-08-10 | $21.35M derived: sum of 3 quarters · filed 2026-08-10 | $27.43M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $6.46M 10-Q · filed 2026-05-13 | $14.62M derived: sum of 2 quarters · filed 2026-05-13 | $20.69M derived: sum of 3 quarters · filed 2026-05-13 | $28.46M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $14.24M derived: sum of 2 quarters · filed 2026-03-23 | $22.01M derived: sum of 3 quarters · filed 2026-03-23 | $30.78M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $6.07M 10-Q · filed 2025-11-13 | $13.84M derived: sum of 2 quarters · filed 2025-11-13 | $22.61M 10-Q · filed 2025-11-13 | $33.33M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $7.77M 10-Q · filed 2025-08-14 | $16.54M 10-Q · filed 2025-08-14 | $27.26M derived: sum of 3 quarters · filed 2025-08-14 | $36.58M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $8.77M 10-Q · filed 2025-05-14 | $19.49M derived: sum of 2 quarters · filed 2025-05-14 | $28.81M derived: sum of 3 quarters · filed 2025-05-14 | $37.47M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $10.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $20.04M derived: sum of 2 quarters · filed 2025-03-31 | $28.70M derived: sum of 3 quarters · filed 2025-03-31 | $36.12M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $9.32M 10-Q · filed 2024-11-14 | $17.98M derived: sum of 2 quarters · filed 2024-11-14 | $25.39M 10-Q · filed 2024-11-14 | $33.61M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $8.66M 10-Q · filed 2024-08-07 | $16.08M 10-Q · filed 2024-08-07 | $24.29M derived: sum of 3 quarters · filed 2024-08-07 | $31.51M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $7.42M 10-Q · filed 2024-05-08 | $15.63M derived: sum of 2 quarters · filed 2024-05-08 | $22.85M derived: sum of 3 quarters · filed 2024-05-08 | $29.52M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $15.44M derived: sum of 2 quarters · filed 2024-03-05 | $22.11M derived: sum of 3 quarters · filed 2024-03-05 | $27.80M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $7.22M 10-Q · filed 2023-11-08 | $13.89M derived: sum of 2 quarters · filed 2023-11-08 | $19.59M 10-Q · filed 2023-11-08 | $25.89M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $6.67M 10-Q · filed 2023-08-09 | $12.37M 10-Q · filed 2023-08-09 | $18.67M derived: sum of 3 quarters · filed 2023-08-09 | $23.32M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $5.70M 10-Q · filed 2023-05-09 | $12.00M derived: sum of 2 quarters · filed 2023-05-09 | $16.65M derived: sum of 3 quarters · filed 2023-05-09 | $20.51M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $10.96M derived: sum of 2 quarters · filed 2023-03-09 | $14.81M derived: sum of 3 quarters · filed 2023-03-09 | $17.98M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $4.66M 10-Q · filed 2022-11-03 | $8.51M derived: sum of 2 quarters · filed 2022-11-03 | $11.68M 10-Q · filed 2022-11-03 | $15.67M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $3.86M 10-Q · filed 2022-08-04 | $7.02M 10-Q · filed 2022-08-04 | $11.01M derived: sum of 3 quarters · filed 2022-08-04 | $13.21M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $3.17M 10-Q · filed 2022-05-05 | $7.16M derived: sum of 2 quarters · filed 2022-05-05 | $9.35M derived: sum of 3 quarters · filed 2022-05-05 | $10.54M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.19M derived: sum of 2 quarters · filed 2022-03-01 | $7.37M derived: sum of 3 quarters · filed 2022-03-01 | $8.50M 10-K · filed 2022-03-01 | $8.50M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $2.20M 10-Q · filed 2021-11-04 | $3.38M derived: sum of 2 quarters · filed 2021-11-04 | $4.51M 10-Q · filed 2021-11-04 | $7.30M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $1.18M 10-Q · filed 2021-08-04 | $2.32M 10-Q · filed 2021-08-04 | $5.11M derived: sum of 3 quarters · filed 2021-08-04 | $8.42M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $1.14M 10-Q · filed 2021-05-13 | $3.93M derived: sum of 2 quarters · filed 2021-05-13 | $7.24M derived: sum of 3 quarters · filed 2021-05-13 | $9.41M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $2.79M 10-K · filed 2020-03-10 | $6.10M derived: sum of 2 quarters · filed 2020-11-13 | $8.28M derived: sum of 3 quarters · filed 2020-11-13 | $10.13M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | $3.31M 10-Q · filed 2020-11-13 | $3.31M 10-Q · filed 2019-11-07 | $5.49M derived: sum of 2 quarters · filed 2020-11-13 | $7.34M 10-Q · filed 2020-11-13 | $7.34M 10-Q · filed 2019-11-07 | $11.35M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $2.17M 10-Q · filed 2020-08-13 | $2.17M 10-Q · filed 2019-08-08 | $4.03M 10-Q · filed 2020-08-13 | $4.03M 10-Q · filed 2019-08-08 | $8.04M derived: sum of 3 quarters · filed 2020-08-13 | $10.87M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $1.85M 10-Q · filed 2020-06-18 | $1.85M 10-Q · filed 2019-05-09 | $5.87M derived: sum of 2 quarters · filed 2020-06-18 | $8.70M derived: sum of 3 quarters · filed 2020-06-18 | $12.09M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | $4.01M 10-K · filed 2020-03-10 | $6.84M derived: sum of 2 quarters · filed 2020-03-10 | $10.23M derived: sum of 3 quarters · filed 2020-03-10 | $12.00M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $2.83M 10-K · filed 2020-03-10 | $6.22M derived: sum of 2 quarters · filed 2020-03-10 | $7.99M 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | $3.39M 10-K · filed 2020-03-10 | $5.16M 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | $1.77M 10-K · filed 2020-03-10 | |||||||
| 2017-09-30 | $2.74M 10-Q · filed 2018-11-07 | $6.66M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |